|
Market Closed -
Nasdaq
16:30:00 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 18.30 USD | -0.49% |
|
+0.44% | +92.83% |
| 08-13 | Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Fortress Biotech, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 97.72M | - | - | - | ||
| 82.73B | |||||
| 57.94B | |||||
| 55.45B | - | ||||
| 52.57B | |||||
| 48.94B |
Select your edition
All financial news and data tailored to specific country editions
